Observational studyMedicine2019
Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma.
Youn Young Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled itcites it